263 related articles for article (PubMed ID: 11935304)
1. Epidermal growth factor receptor expression in invasive thymoma.
Henley JD; Koukoulis GK; Loehrer PJ
J Cancer Res Clin Oncol; 2002 Mar; 128(3):167-70. PubMed ID: 11935304
[TBL] [Abstract][Full Text] [Related]
2. Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors.
Suzuki E; Sasaki H; Kawano O; Endo K; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
Jpn J Clin Oncol; 2006 Jun; 36(6):351-6. PubMed ID: 16762968
[TBL] [Abstract][Full Text] [Related]
3. Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomas.
Meister M; Schirmacher P; Dienemann H; Mechtersheimer G; Schnabel PA; Kern MA; Herpel E; Xu EC; Muley T; Thomas M; Rieker RJ
Cancer Lett; 2007 Apr; 248(2):186-91. PubMed ID: 16919868
[TBL] [Abstract][Full Text] [Related]
4. Mutational status of EGFR and KIT in thymoma and thymic carcinoma.
Yoh K; Nishiwaki Y; Ishii G; Goto K; Kubota K; Ohmatsu H; Niho S; Nagai K; Saijo N
Lung Cancer; 2008 Dec; 62(3):316-20. PubMed ID: 18448188
[TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation: common in thymic carcinomas, rare in thymomas.
Suzuki M; Chen H; Shigematsu H; Ando S; Iida T; Nakajima T; Fujisawa T; Kimura H
Oncol Rep; 2005 Dec; 14(6):1621-4. PubMed ID: 16273266
[TBL] [Abstract][Full Text] [Related]
6. Protein expression and gene amplification of epidermal growth factor receptor in thymomas.
Ionescu DN; Sasatomi E; Cieply K; Nola M; Dacic S
Cancer; 2005 Feb; 103(3):630-6. PubMed ID: 15630697
[TBL] [Abstract][Full Text] [Related]
7. Absence of gene mutations in KIT-positive thymic epithelial tumors.
Tsuchida M; Umezu H; Hashimoto T; Shinohara H; Koike T; Hosaka Y; Eimoto T; Hayashi JI
Lung Cancer; 2008 Dec; 62(3):321-5. PubMed ID: 18486988
[TBL] [Abstract][Full Text] [Related]
8. [Correlation between clinical aggressiveness of thymic epithelial tumors and expression of tumor suppressor gene products (p53, p27)].
Fukiwake N; Kase S; Yamazaki K; Yano T; Sugimachi K
Fukuoka Igaku Zasshi; 1999 Aug; 90(8):339-41. PubMed ID: 10496046
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 is correlated with poor prognostic variables in patients with thymic epithelial tumors.
Sogawa K; Kondo K; Fujino H; Takahashi Y; Miyoshi T; Sakiyama S; Mukai K; Monden Y
Cancer; 2003 Nov; 98(9):1822-9. PubMed ID: 14584061
[TBL] [Abstract][Full Text] [Related]
10. Expression of neurotrophin receptors in surgically resected thymic epithelial tumors.
Kim DJ; Yang WI; Kim SH; Park IK; Chung KY
Eur J Cardiothorac Surg; 2005 Oct; 28(4):611-6. PubMed ID: 16125946
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies.
Scartozzi M; Bearzi I; Berardi R; Mandolesi A; Fabris G; Cascinu S
J Clin Oncol; 2004 Dec; 22(23):4772-8. PubMed ID: 15570078
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder.
Wang X; Zhang S; MacLennan GT; Eble JN; Lopez-Beltran A; Yang XJ; Pan CX; Zhou H; Montironi R; Cheng L
Clin Cancer Res; 2007 Feb; 13(3):953-7. PubMed ID: 17289890
[TBL] [Abstract][Full Text] [Related]
13. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.
Thomas DG; Giordano TJ; Sanders D; Biermann S; Sondak VK; Trent JC; Yu D; Pollock RE; Baker L
Cancer; 2005 Feb; 103(4):830-8. PubMed ID: 15641030
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor expression and gene copy number in fibrolamellar hepatocellular carcinoma.
Buckley AF; Burgart LJ; Kakar S
Hum Pathol; 2006 Apr; 37(4):410-4. PubMed ID: 16564914
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical staining for bcl-2 and mcl-1 in intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) and cervical thymic carcinoma.
Dorfman DM; Shahsafaei A; Miyauchi A
Mod Pathol; 1998 Oct; 11(10):989-94. PubMed ID: 9796728
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine kinase receptor expression in thymomas.
Henley JD; Cummings OW; Loehrer PJ
J Cancer Res Clin Oncol; 2004 Apr; 130(4):222-4. PubMed ID: 14762710
[TBL] [Abstract][Full Text] [Related]
17. Expression of HER-2/neu oncoprotein and epidermal growth factor receptor and prognosis in gastric carcinoma.
Lee EY; Cibull ML; Strodel WE; Haley JV
Arch Pathol Lab Med; 1994 Mar; 118(3):235-9. PubMed ID: 7907854
[TBL] [Abstract][Full Text] [Related]
18. [Grading of malignancy of thymomas by flow cytometry].
Liu H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Aug; 14(4):310-3. PubMed ID: 1473222
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of p63 and XIAP in thymic hyperplasia and thymomas.
Wu M; Sun K; Gil J; Gan L; Burstein DE
Am J Clin Pathol; 2009 May; 131(5):689-93. PubMed ID: 19369629
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor expression and mutational analysis in synovial sarcomas and malignant peripheral nerve sheath tumors.
Tawbi H; Thomas D; Lucas DR; Biermann JS; Schuetze SM; Hart AL; Chugh R; Baker LH
Oncologist; 2008 Apr; 13(4):459-66. PubMed ID: 18448562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]